About Us
Adikan Healthcare Private Limited, a professionally managed pharmaceutical company, was incorporated on 21st June 2012.
Please fill out the form below and we will get back to you as soon as possible.
Adikan Healthcare Private Limited, a professionally managed pharmaceutical company, was incorporated on 21st June 2012.
Rifaximin 550 mg Tablets
Gastroenterology
Hepatic Encephalopathy recurrence prevention; IBS-D
NTRIF 550 is the higher-strength formulation of Rifaximin — the clinically validated dose for prevention of recurrent Hepatic Encephalopathy episodes in patients with advanced liver disease, and for IBS-D where higher dosing is clinically indicated.
• 550 mg dose for more demanding clinical indications
• Proven in reducing recurrence of overt Hepatic Encephalopathy
• Gut-selective broad-spectrum antibiotic — minimal systemic side-effect profile
• Well-tolerated for extended use in HE maintenance therapy
• Anti-inflammatory and gut mucosal protective properties